Journal of Infectious Diseases
Volume 223, Issue 9, 1 May 2021
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics
Michael S Sinha, John H Powers, III, Aaron S Kesselheim
The Journal of Infectious Diseases, Volume 223, Issue 9, 1 May 2021, Pages 1506–1509, https://doi.org/10.1093/infdis/jiaa536
Though antimicrobial resistance is a public health concern, the basis of approval for many new antibiotics does not distinguish them from older products. We suggest a more tailored incentive structure for antibiotic development, focused on clinical benefit and patient outcomes.